Literature DB >> 3182073

Virulence conversion of Legionella pneumophila: a one-way phenomenon.

C E Catrenich1, W Johnson.   

Abstract

Previous investigations have shown that Legionella pneumophila converts from virulence to avirulence after passage on supplemented Mueller-Hinton (SMH) agar and may convert back to virulence after passage in guinea pigs. However, there is no additional information concerning the apparent interconversion of virulent and avirulent derivatives of L. pneumophila cultures. We investigated the stability of a parental virulent culture and its avirulent derivatives and the growth and viability of these cultures on charcoal-yeast extract (CYE) and SMH agars. Avirulent derivatives of a highly virulent L. pneumophila culture were obtained by passage of the virulent parent culture on SMH agar. The only time a virulent L. pneumophila culture was recoverable from an avirulent culture was when the avirulent culture was derived from a saline suspension of a virulent culture which had been passaged only five times on SMH agar. When an avirulent culture was derived from a virulent culture passaged 25 times on SMH agar or from an isolated colony which grew on a SMH agar plate, we were unable to recover a virulent culture after successive passage through guinea pigs. These results suggest that the conversion process which occurs between virulent and avirulent forms of L. pneumophila is a one-way phenomenon from virulence to avirulence and that stable avirulent derivatives can be isolated. Furthermore, our findings suggest that SMH agar acts as a selective medium for the growth of avirulent L. pneumophila, and growth on SMH agar may be a phenotypic marker for avirulence. Virulent cells, although unable to grow on SMH agar, may remain viable for several passages on SMH agar and propagate when inoculated into guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182073      PMCID: PMC259711          DOI: 10.1128/iai.56.12.3121-3125.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Genetic analysis of phase change in Bordetella pertussis.

Authors:  A A Weiss; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

2.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

3.  Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice.

Authors:  M C Maayan; I Ofek; O Medalia; M Aronson
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Virulence conversion of Legionella pneumophila serogroup 1 by passage in guinea pigs and embryonated eggs.

Authors:  J A Elliott; W Johnson
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Virulent to avirulent conversion of Legionnaires' disease bacterium (Legionella pneumophila)--its effect on isolation techniques.

Authors:  J E McDade; C C Shepard
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

6.  Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila.

Authors:  J C Feeley; R J Gibson; G W Gorman; N C Langford; J K Rasheed; D C Mackel; W B Baine
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

7.  Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant.

Authors:  R AUSTRIAN
Journal:  J Exp Med       Date:  1953-07       Impact factor: 14.307

  7 in total
  18 in total

1.  Infection of macrophages with Legionella pneumophila induces phosphorylation of a 76-kilodalton protein.

Authors:  Y Yamamoto; T W Klein; H Shinomiya; M Nakano; H Friedman
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Acquisition of iron by Legionella pneumophila: role of iron reductase.

Authors:  W Johnson; L Varner; M Poch
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  A quantitative model of intracellular growth of Legionella pneumophila in Acanthamoeba castellanii.

Authors:  J F Moffat; L S Tompkins
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Virulence of Paracoccidiodes brasiliensis: the influence of in vitro passage and storage.

Authors:  E Brummer; A Restrepo; L H Hanson; D A Stevens
Journal:  Mycopathologia       Date:  1990-01       Impact factor: 2.574

5.  Elevated levels of Legionella pneumophila stress protein Hsp60 early in infection of human monocytes and L929 cells correlate with virulence.

Authors:  R C Fernandez; S M Logan; S H Lee; P S Hoffman
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Identification of Legionella pneumophila genes important for infection of amoebas by signature-tagged mutagenesis.

Authors:  A H Polesky; J T Ross; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Identification of Legionella pneumophila genes required for growth within and killing of human macrophages.

Authors:  A B Sadosky; L A Wiater; H A Shuman
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion.

Authors:  J D Cirillo; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Gentamicin-Containing Peptone-Yeast Extract Medium for Cocultivation of Hartmannella vermiformis ATCC 50256 and Virulent Strains of Legionella pneumophila.

Authors:  R M Wadowsky; L Wang; S Laus; J N Dowling; J M Kuchta; S J States; R B Yee
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

10.  Characterization of the selective inhibition of growth of virulent Legionella pneumophila by supplemented Mueller-Hinton medium.

Authors:  C E Catrenich; W Johnson
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.